![Quiver Logo](/static/img/logo-icon.png)
![MGTX logo](https://quiver-logos.s3.us-east-2.amazonaws.com/mgtx.png)
MeiraGTx Holdings plc Ordinary Shares
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view MGTX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of MGTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MGTX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to MGTX
Recent picks made for MGTX stock on CNBC
ETFs with the largest estimated holdings in MGTX
Flights by private jets registered to MGTX
![Quiver Logo](/static/img/logo-icon.png)